ArticleJournal of thoracic disease2025
Predicting severe community-acquired pneumonia in adults: a machine learning approach using C-reactive protein to albumin ratio.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Community-acquired pneumonia (CAP) can rapidly progress to severe disease, markedly increasing mortality. This study aimed to investigate the value of C-reactive protein to albumin ratio (CAR) and its incorporation into machine learning models for predicting the progression of CAP to severe pneumonia in adults. These findings may provide new insights and a new tool for early risk assessment and clinical decision-making for patients with CAP. Methods: Clinical data of 117 patients diagnosed with CAP and hospitalized in our institution between June 2023 and April 2024 were used. The patients were divided into severe and non-severe CAP groups based on discharge diagnoses. Univariate analysis and random forest (RF) modeling were employed to select feature. For inclusion in five machine learning models logistic regression (LR), multilayer perceptron (MLP), support vector machine (SVM), extreme gradient boosting (XGBoost), and RF. The predictive performance of these models was evaluated using the accuracy, F1-score, and area under the receiver operating characteristic curve (AUC). Results: Based on univariate analysis and RF CAR, age, and neutrophil count were selected for model inclusion. All models demonstrated good predictive performance with accuracy exceeding 78%. The MLP model performed best across all three evaluation metrics (accuracy =85.11%, F1-score =0.70, AUC =0.89). The CAR contributed most to the predictive model. Conclusions: The CAR, along with the age and neutrophil count, effectively predicts the severe pneumonia risk in patients with CAP, and the MLP model enhances prediction accuracy for early risk assessment and clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.